Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Inflammation Research|July 18, 2022
Pyroptosis: A Novel Intervention Target in the Progression of OsteoarthritisXingyu Chang, Yuchen Kang, Yuxuan Yang, et al.Orthopaedic Surgery|July 5, 2023
Research Progress of Nanomaterials in Chemotherapy of OsteosarcomaTianci Yu, Zongyan Cai, Xingyu Chang, et al.International Journal of Molecular Medicine|September 16, 2021
CircRNA: A novel potential strategy to treat thyroid cancer (Review)Guomao Zhu, Xingyu Chang, Yuchen Kang, et al.Frontiers in Endocrinology|December 3, 2021
miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic RetinopathyXingyu Chang, Guomao Zhu, Zongyan Cai, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 28, 2025
Decoding Triphenotypic Neutrophils in Cervical Cancer Evolution and Targeting SPP1+/GBP1+/ELOVL5+ Tumor-Associated Neutrophils to Sensitize ImmunotherapyXingyu Chang, Xinyu Qu, Tingting Ren, et al.Journal of Medicinal Chemistry|February 24, 2023
Tumor-Targeting NHC-Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular CarcinomaZhibin Yang, Mianli Bian, Lin Lv, et al.Pharmacological Research|November 20, 2022
Induction of immunogenic cell death by novel platinum-based anticancer agentsXingyu Chang, Mianli Bian, Lijuan Liu, et al.Precision Clinical Medicine|March 25, 2026
Therapeutic strategy for cervical gastric-type adenocarcinoma by targeting CLU to relieve CLU-associated stress and sensitize chemotherapyTong Wu, Xinyu Qu, Lili Jiang, et al.Chemical Society Reviews|June 14, 2022
Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseasesYunlong Lu, Xiaoyan Ma, Xingyu Chang, et al.Frontiers in Immunology|February 7, 2025
Identification and validation of glycolysis-related diagnostic signatures in diabetic nephropathy: a study based on integrative machine learning and single-cell sequenceXiaoyin Wu, Buyu Guo, Xingyu Chang, et al.Pageof 3